Home/Filings/4/0001214659-17-007028
4//SEC Filing

Wasoff Evan L 4

Accession 0001214659-17-007028

CIK 0001625288other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 1:08 PM ET

Size

4.9 KB

Accession

0001214659-17-007028

Insider Transaction Report

Form 4
Period: 2017-11-29
Wasoff Evan L
Chief Financial Officer
Transactions
  • Other

    Common Stock

    2017-11-29+629,1281,000,000 total
Footnotes (2)
  • [F1]As adjusted to reflect a one-for-six reverse split of the issuer's common stock effective November 29, 2017
  • [F2]Acquired in exchange for all of Evan Wasoff's shares of Intiva BioPharma Inc.

Issuer

Intiva BioPharma Inc.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001719738

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 1:08 PM ET
Size
4.9 KB